| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 06/12/2013 | CN103145568A Cardanol cationoid quaternary ammonium salt and preparation method thereof |
| 06/12/2013 | CN103145567A Quaternary ammonium salt of cardanol polyoxyethylene ether and preparation method thereof |
| 06/12/2013 | CN103145559A Preparation method of N-allyl arylamine |
| 06/12/2013 | CN102093230B Type I forked biphenyl diamine and preparation method and application thereof |
| 06/12/2013 | CN101522631B Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 06/11/2013 | CA2656696C Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine |
| 06/06/2013 | WO2013080095A1 Process for the preparation of agomelatine |
| 06/06/2013 | WO2013037705A3 Aniline derivatives,their preparation and their therapeutic application |
| 06/06/2013 | US20130143846 Polymorphic form of a calcimimetic compound |
| 06/05/2013 | CN103140465A Methods of synthesizing 2-methoxymethyl-1,4-benzenediamine |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 06/05/2013 | CN103130661A Crystal and amorphous substance of dapoxetine hydrochloride and preparation method thereof |
| 06/05/2013 | CN103130660A Acidic salt and crystal of dapoxetine and preparation method of crystal |
| 06/05/2013 | CN103130659A Crystal of acidic salt of dapoxetine and preparation method thereof |
| 06/05/2013 | CN103130658A Dapoxetine hydrochlorate crystal form A and preparation method thereof |
| 06/05/2013 | CN103130594A Method preparing N-aryl and N-alkyl aromatic amine type compound from phenol type compound |
| 06/05/2013 | CN102285904B Method for preparing rivastigmine |
| 05/30/2013 | WO2013077949A1 Amine sulfide scavengers, methods of using, and methods of making |
| 05/30/2013 | WO2013075671A1 Crystals of acid salts and acid salts of dapoxetine and preparation methods therefor |
| 05/30/2013 | WO2013075670A1 Acid salts of dapoxetine hydrochloride and preparation methods therefor |
| 05/30/2013 | WO2013075669A1 Crystal and amorphous substance of dapoxetine hydrochloride and preparation method therefor |
| 05/29/2013 | CN103124718A Methods of synthesizing 2-substituted-1,4-benzenediamine |
| 05/29/2013 | CN103124717A Method for the selective production of N-methyl-para-anisidine |
| 05/29/2013 | CN103121958A Blowing catalyst compositions containing hydroxyl and surface active groups for the production of polyurethane foams |
| 05/29/2013 | CN101973897B Synthesis method of valdoxan intermediate 2-(7-methoxy-1-naphthyl)ethylamine |
| 05/29/2013 | CN101881755B Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography |
| 05/29/2013 | CN101774874B N-arylating method using pyrrole-2-hydrazide compound as ligand in aqueous phase system |
| 05/29/2013 | CN101691318B N-arylation method taking substituted adipic dihydrazide as ligand in aqueous phase system |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/29/2013 | CN101495447B Preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamine |
| 05/28/2013 | US8450528 Process for the preparation of 2,2-difluoroethylamine starting from a benzylamine compound |
| 05/23/2013 | WO2013073331A1 Method for forming copper film, copper film, circuit substrate, and copper-film-forming composition solution |
| 05/23/2013 | US20130131387 Methods and compounds for improving sulfide scavenging activity |
| 05/23/2013 | US20130131023 New polymorphic form of a calcimimetic compound |
| 05/23/2013 | US20130126429 Amine sulfide scavengers, methods of using, and methods of making |
| 05/22/2013 | EP2593096A2 Diclofenac salt of tramadol |
| 05/22/2013 | CN103119015A Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives |
| 05/22/2013 | CN103113575A Reaction type antistatic agent, preparation method and durable antistatic polyurethane material |
| 05/22/2013 | CN103113411A Preparation method of mono-chiral metallic organic frame material with function of splitting chiral amine |
| 05/22/2013 | CN103113292A Novel dapoxetine nicotinamide eutectic crystal form |
| 05/22/2013 | CN103113243A Synthetic method of 2-(7-methoxyl-1-naphthyl) ethylamine hydrochloride |
| 05/22/2013 | CN103113242A Functional choline chloride ionic liquid and preparation method and application in electrochemical energy storage device thereof |
| 05/22/2013 | CN103113241A Synthetic method of diethylaminoethoxyethanol |
| 05/22/2013 | CN102127030B 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof |
| 05/16/2013 | WO2013070660A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/16/2013 | US20130123338 Novel cationic lipids and methods of use thereof |
| 05/16/2013 | CA2854836A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| 05/15/2013 | CN103102281A Synthesis method of metoprolol succinate |
| 05/14/2013 | US8440851 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/10/2013 | WO2013065825A1 Cationic lipid |
| 05/10/2013 | WO2013065755A1 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | CA2854066A1 Cationic lipid |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/08/2013 | EP2588445A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | EP2588444A1 New polymorphic form of a calcimimetic compound |
| 05/08/2013 | EP2588429A1 New process for the synthesis of tapentadol and intermediates thereof |
| 05/08/2013 | CN103086898A Preparation method of diphenylamine or ring-substituted derivative thereof |
| 05/08/2013 | CN103086897A Method for preparing o-oxydianiline from reducing o-nitrophenyl ether by hydrazine hydrate |
| 05/08/2013 | CN101823970B Synthetic method of rivastigmine and intermediates thereof |
| 05/08/2013 | CN101641322B Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent |
| 05/07/2013 | US8435557 Method for producing sterile polynucleotide based medicaments |
| 05/02/2013 | US20130109713 Antimicrobial agents |
| 05/01/2013 | CN103080058A Aromatic compound containing specific branch |
| 05/01/2013 | CN103079534A "green" diester amines and personal care products |
| 05/01/2013 | CN103073441A Novel method for compositing (7- methoxy-1-naphthyl) and application of method in compositing of agomelatine |
| 05/01/2013 | CN103073440A Diphenylvinyloxy alkylamine compound and preparation method as well as application thereof |
| 05/01/2013 | CN103073436A Method of preparing o-anisidine and p-anisidine through hydrogenation reduction of mixture of o-nitroanisole and p-nitroanisole |
| 05/01/2013 | CN101885652B Method for preparing aromatic secondary amine |
| 04/25/2013 | US20130102794 Novel Process for the Preparation of Nitrogen Substituted Aminotetralins Derivatives |
| 04/25/2013 | US20130101684 Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste |
| 04/24/2013 | EP2583960A1 Process for production of intermediate for cyclic carbodiimide compound |
| 04/24/2013 | EP2582659A2 Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds |
| 04/24/2013 | CN103068721A Process for producing hydrogen or heavy hydrogens, and hydrogenation (protiation, deuteration or tritiation) of organic compounds using same |
| 04/24/2013 | CN103058805A Method for synthesizing amine and imine |
| 04/24/2013 | CN101698648B Novel multidentate monophenol oxygroup ligand zinc complex and preparation method and application thereof |
| 04/24/2013 | CN101602680B Naphthyl ethylamine derivative and preparation method thereof and application of naphthyl ethylamine derivative in preparing weight-reducing medicament |
| 04/18/2013 | WO2013055971A1 Polymers for delivering a substance into a cell |
| 04/18/2013 | WO2013054273A2 Process for the preparation of agomelatine |
| 04/18/2013 | WO2013053046A1 Iron bisphenolate complexes and methods of use and synthesis thereof |
| 04/18/2013 | US20130096319 Process for preparation of amisulpride |
| 04/17/2013 | EP2580183A2 New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide and new crystalline form |
| 04/17/2013 | CN103045232A Dihydro-pentacene-olefin organic light-emitting material, preparation method and application of dihydro-pentacene-olefin organic light-emitting material |
| 04/17/2013 | CN103044276A Process for preparing 4,4-diaminodiphenyl ether |
| 04/17/2013 | CN103044275A Qaternized aromatic compound, polyketone with quaternary aromatic groups and methods for preparing quaternized aromatic compound and polyketone with quaternary aromatic groups |
| 04/17/2013 | CN102142316B Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery |
| 04/17/2013 | CN101851167B Method for synthesizing prochloraz intermediate |
| 04/17/2013 | CN101851166B Synthesis method for prochloraz intermediate |
| 04/17/2013 | CN101747214B Preparation of optical counterpart of novel anti-hypertensive compound |
| 04/17/2013 | CN101560165B Preparation method of 2,2-bi[4-(2-trifluoromethyl-4-aminophenoxyl)phenyl]hexafluoropropane |
| 04/17/2013 | CN101486660B Preparation of 2,2-bis[4-(2-trifluoromethyl-4-aminophenoxy)phenyl] propane |
| 04/16/2013 | US8420860 Compound and color filter |
| 04/16/2013 | US8420768 Polymerizable higher diamondoid derivatives |
| 04/14/2013 | CA2755147A1 Iron bisphenolate complexes and methods of use and synthesis thereof |
| 04/11/2013 | US20130090386 Lysine specific demethylase-1 inhibitors and their use |
| 04/11/2013 | US20130090372 Novel Low Molecular Weight Cationic Lipids for Oligonucleotide Delivery |
| 04/10/2013 | EP2575767A1 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 04/10/2013 | CN103030567A Propranolol medicine enantiomer resolution method |
| 04/10/2013 | CN103030566A Fluoranthene organic semiconductor material and preparing method and application thereof |
| 04/10/2013 | CN102146044B Preparation method of propranolol hydrochloride single enantiomers |